Heterogeneity of the tumor immune microenvironment and its clinical relevanceQingzhu Jia, Haixia Long|Experimental Hematology and Oncology|2022Cited by 337
CD200 <sup>+</sup> cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti–PD-1/PD-L1 therapyXinxin Wang, Bo Zhu, Zhongyu Wang et al.|Science Translational Medicine|2023Cited by 34
DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular trapsDegao Chen, Chu Han, Yucui Wu et al.|Cancer Cell|2025Cited by 28
Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategyTing Yuan, Haixia Long, Qingzhu Jia et al.|Cell Communication and Signaling|2023Cited by 16